The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
This is crazy. You can now buy cheaper than beofre FDA. Fill your boots imo
Courtesy of Telegraph Questor column in Feb 2021:
Should authorisation be granted, the financial as well as medical benefits should quickly be visible. Boxall said Polarean was already talking to hospitals with a view to making sales quickly. It shouldnt be difficult to sell, he said. It helps that Polarean™ kit is relatively inexpensive next to the cost of the MRI scanner itself.
Spencer-Walsh added: polarean is obviously loss-making at the moment. Its broker forecasts profitability by 2025, then $167m (£119m) of sales in 2030 and profits of $60m. It expects 40pc annual growth in the early years, then 30pc by 2028-29. But it will be bought by then, possibly by Bracco Imaging of Italy, one of its biggest shareholders.
My biggest fear is that it will be bought too soon. Depending on timing, it could fetch £500m-£1bn, against £194m now.â€?
Questor says: speculative buy
Ticker: POLX
Share price at close: 93p
So, a few points to note:
1. We now have authorisation.
2. Our sp is now HALF what it was 2 years ago. In other words, you can buy 'em on a 2 for 1 basis just now.
3. Approx 10p per share is cash.
4. We will probably be bought out at some point within the next 5 years.
Listen to the experts...Robert M Tighe ...Physician and scientist.
Jan 2023
The future is super bright with this technology. 3D lung gas exchange imaging is going to change how we assess lung function in lung disease. I am biased but so much potential to define prognosis, early diagnostics and even therapy responses. More to come!
I don't think we will see 100p today but over the next few weeks this is definitely possible. Holders just need to be patient as there will be some down days to shake out the weak holders and then we will get posters putting a negative spin on Polx to buy chepaer. Over time this will rerate and patient investors will be handsomely rewarded imo
Yes agree. Company should update market very soon .
'No letters are sent to the application holder to indicate that a period of exclusivity has attached to their application. The posting of exclusivity information in the Orange Book is the official vehicle for dissemination of this information'
Strong Buy
This is why we are invested. Excellent presentation
HTtps://youtu.be/Db0IdVAbLYM
I agree heavily oversold. Aim market throws up these opportunities at times this is giving us a gift imo. Technically this looks like it will rise from here. Plenty of upside potential with little down side at this price imo